GO:0003172 sinoatrial valve development: Embryonic Heart Valve Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003172 sinoatrial valve development describes the progression of the sinoatrial (SA) valve from its formation to its mature structure, a key event in the embryonic heart.
• Endocardial NOTCH1 signaling is essential for the development of the sinus venosus valve and the sinoatrial node, linking valve morphogenesis to pacemaker formation.
• Hedgehog signaling controls sinoatrial node development and atrioventricular cushion formation, indicating shared regulatory pathways in heart valve and conduction system development.
• The homeodomain transcription factor Shox2 is required for sinoatrial and pacemaking development, and its mutation disrupts SA valve formation.
• Evolutionary and developmental studies of the sinus venosus and its valves provide operational criteria for comparative heart research.
• Disruption of sinoatrial valve development can lead to congenital heart defects and arrhythmias, making it a target for disease modeling [1,8].
Description
Sinoatrial valve development (GO:0003172) is the biological process by which the sinoatrial valve forms and matures during embryogenesis. This valve, also known as the SA valve, is a critical component of the embryonic heart that helps regulate blood flow between the sinus venosus and the atrium. Understanding its development is essential for uncovering the origins of congenital heart defects and conduction system disorders [1,8]. Research has shown that endocardial NOTCH1 signaling controls both sinus venosus valve and sinoatrial node development, highlighting an intimate link between valve formation and pacemaker function. Similarly, Hedgehog signaling has been implicated in sinoatrial node development and atrioventricular cushion formation, suggesting conserved pathways in heart valve and conduction system morphogenesis. The transcription factor Shox2 is also essential for sinoatrial and pacemaking development, and its targeted mutation disrupts SA valve formation. These findings underscore the importance of GO:0003172 in cardiac developmental biology and disease modeling.
sinoatrial valve development At A Glance
| GO ID | GO:0003172 |
|---|---|
| GO term | sinoatrial valve development |
| Ontology | biological_process |
| Synonym | SA valve development |
| Major function | Formation and maturation of the sinoatrial valve during embryogenesis |
| Related process | Sinus venosus valve development, sinoatrial node development |
| Key regulators | NOTCH1, Hedgehog signaling, Shox2 |
| Associated diseases | Congenital heart defects, arrhythmias |
What Is GO:0003172?
According to the Gene Ontology, GO:0003172 sinoatrial valve development is defined as the progression of the sinoatrial valve over time, from its formation to the mature structure. This process encompasses the cellular and molecular events that lead to the creation of a functional valve that separates the sinus venosus from the atrium in the developing heart [1,5].
Why Is sinoatrial valve development Important in Cell Biology?
Sinoatrial valve development is crucial because defects in this process can lead to congenital heart malformations and arrhythmias [1,8]. The SA valve is essential for proper blood flow in the embryonic heart, and its development is tightly linked to the sinoatrial node, the primary pacemaker. Understanding the molecular mechanisms governing SA valve formation can provide insights into the etiology of cardiac conduction disorders and guide regenerative strategies [3,8].
• Elucidates mechanisms of congenital heart defects involving valve malformations.
• Links valve development to pacemaker formation and arrhythmia susceptibility [1,8].
• Provides evolutionary insights into heart chamber separation.
• Identifies signaling pathways (NOTCH, Hedgehog) as potential therapeutic targets [1,3].
• Highlights the role of transcription factors like Shox2 in cardiac development.
• Informs tissue engineering approaches for heart valve replacement.
• Serves as a model for studying endothelial-to-mesenchymal transition in valves.
• Contributes to understanding left-right patterning and heart morphogenesis.
What Happens During sinoatrial valve development?
Initiation of sinoatrial valve formation
In simple terms: The heart starts to form a valve between the sinus venosus and the atrium.
Sinoatrial valve development begins with the specification of endocardial cells in the sinus venosus region. Endocardial NOTCH1 signaling is required for the initial formation of the sinus venosus valve, as shown in mouse models where Notch1 deletion disrupts valve development. This early phase involves complex signaling interactions that pattern the heart tube and establish the valve primordium [1,6].
Endocardial-to-mesenchymal transition and cushion formation
In simple terms: Cells in the valve region change type and build a cushion that will become the valve.
Following initiation, endocardial cells undergo endothelial-to-mesenchymal transition (EndMT) and invade the underlying extracellular matrix to form endocardial cushions. Hedgehog signaling controls atrioventricular cushion formation, and its perturbation affects sinoatrial node development, suggesting a shared mechanism in valve and conduction system morphogenesis. These cushions serve as precursors for the mature valve leaflets.
Maturation and remodeling of the sinoatrial valve
In simple terms: The cushion reshapes into a thin, functional valve.
The endocardial cushions are subsequently remodeled into mature valve leaflets through processes involving cell proliferation, apoptosis, and extracellular matrix reorganization. Shox2, a homeodomain transcription factor, is essential for sinoatrial and pacemaking development; its mutation leads to defective SA valve formation, indicating a role in maturation. The mature sinoatrial valve ensures unidirectional blood flow in the embryonic heart.
Integration with sinoatrial node development
In simple terms: The valve and the heart's natural pacemaker develop together.
Sinoatrial valve development is closely coordinated with the development of the sinoatrial node, the primary pacemaker. NOTCH1 signaling simultaneously controls both sinus venosus valve and sinoatrial node development, as demonstrated by conditional knockout studies. This integration ensures proper electrical and mechanical function of the embryonic heart [1,3].
Evolutionary and comparative aspects
In simple terms: Studying different animals helps us understand how this valve evolved.
The sinoatrial valve is present in various vertebrates, and its development has been studied in dogfish (Scyliorhinus canicula), providing insights into the evolutionary origins of the sinus venosus and its valves. Operational criteria for developmental and evolutionary studies of sinus venosus incorporation have been proposed to standardize comparative analyses.
Key Genes Involved in GO:0003172 sinoatrial valve development
The following genes and proteins have been experimentally implicated in sinoatrial valve development and related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Endocardial signaling; required for sinus venosus valve and sinoatrial node development | Conditional knockout models show valve agenesis |
| Shox2 | Homeodomain transcription factor; essential for sinoatrial and pacemaking development | Targeted mutation disrupts SA valve formation |
| Hedgehog signaling components (e.g., Shh, Ihh) | Controls sinoatrial node development and atrioventricular cushion formation | Perturbation affects valve and conduction system |
| Furina | Proprotein convertase; regulated by RNA regulon; important for left-right patterning and cardiac valve function | Translational control affects heart morphogenesis |
| Scyliorhinus canicula orthologs | Model for sinoatrial valve anatomy and development | Evolutionary insights into valve structure |
| Sinus venosus incorporation genes | Operational criteria for developmental and evolutionary studies | Comparative heart research |
| EndMT regulators (e.g., TGF-β, BMP) | Drive endothelial-to-mesenchymal transition in valve cushions | Implicated in valve formation |
| Extracellular matrix proteins | Provide structural support for valve leaflets | Remodeling during maturation |
| Pacemaker channel genes (e.g., Hcn4) | Function in sinoatrial node; co-regulated with valve development | Linked to arrhythmias |
| NOTCH1 downstream targets (e.g., Hey2, Hes1) | Mediate transcriptional responses in endocardium | Potential effectors in valve development |
| Shox2 targets | Regulate pacemaking and valve genes | Mutation causes SA valve defects |
| Hedgehog pathway effectors (Gli1, Ptch1) | Transduce Hedgehog signals in cushion mesenchyme | Modulate valve and node development |
| Furin substrates | Include TGF-β precursors; affect valve morphogenesis | Furina RNA regulon controls translation |
| Cardiac transcription factors (e.g., Nkx2-5, Tbx5) | Broadly pattern the heart; may interact with SA valve genes | Candidate modifiers |
| Vascular endothelial growth factors | Influence endocardial cell behavior | Potential role in valve vascularization |
| Matrix metalloproteinases | Remodel extracellular matrix during valve maturation | Implicated in cushion remodeling |
| Apoptosis regulators | Control cell death during valve sculpting | Required for mature valve structure |
How Is sinoatrial valve development Regulated?
Sinoatrial valve development is regulated by a complex network of signaling pathways and transcription factors. Endocardial NOTCH1 signaling is a key regulator, as its inactivation leads to defective sinus venosus valve and sinoatrial node development. Hedgehog signaling also plays a critical role, controlling both sinoatrial node development and atrioventricular cushion formation. The homeodomain transcription factor Shox2 is essential for sinoatrial and pacemaking development, and its mutation disrupts SA valve formation. Additionally, translational control of furina by an RNA regulon is important for left-right patterning, heart morphogenesis, and cardiac valve function, indicating post-transcriptional regulation. These pathways are integrated to ensure proper timing and morphogenesis of the sinoatrial valve.
sinoatrial valve development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Congenital heart valve defects, arrhythmias | Conditional knockout mouse |
| Shox2 | Sinus node dysfunction, SA valve defects | Targeted mutation mouse |
| Hedgehog signaling genes | Atrioventricular cushion defects, conduction disorders | Zebrafish or mouse mutants |
| Furina | Left-right patterning defects, cardiac valve dysfunction | RNA regulon mutant models |
| Sinus venosus incorporation genes | Evolutionary heart malformations | Comparative animal models |
Congenital heart defects
Disruption of sinoatrial valve development can result in congenital heart defects, including malformations of the sinus venosus and atrial septum. NOTCH1 mutations have been associated with valve disease, and animal models with Notch1 deletion exhibit severe valve defects. Shox2 mutations cause sinus node dysfunction and SA valve abnormalities, linking developmental defects to arrhythmias.
Arrhythmias and conduction disorders
The close developmental relationship between the sinoatrial valve and the sinoatrial node means that defects in valve formation can lead to conduction abnormalities. NOTCH1 and Hedgehog signaling perturbations affect both valve and node development, potentially causing sick sinus syndrome [1,3]. Shox2 haploinsufficiency in humans is associated with sinus node dysfunction.
Evolutionary and comparative pathology
Studies in dogfish and other vertebrates reveal conserved and divergent features of sinoatrial valve development, providing context for human cardiac evolution and disease [5,6]. Understanding these evolutionary aspects can inform regenerative medicine approaches.
From sinoatrial valve development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NOTCH1 deletion disrupt SA valve development? | Endothelial-specific Notch1 knockout mouse |
| What is the role of Shox2 in SA valve formation? | Shox2 knockout or knock-in mouse |
| How does Hedgehog signaling affect SA node and cushions? | Conditional Hedgehog pathway mutants |
| What is the function of furina in cardiac valve development? | Furina point mutation or overexpression zebrafish |
| How does sinus venosus incorporation occur evolutionarily? | Comparative studies in dogfish and other vertebrates [5,6] |
| Can SA valve development be visualized in real time? | Transgenic reporter lines (e.g., Notch1-GFP) |
How to Study the sinoatrial valve development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Conditional knockout | Gene function in specific tissues | Endothelial Notch1 deletion |
| CRISPR/Cas9 mutagenesis | Gene disruption and phenotype | Shox2 knockout |
| RNA sequencing | Transcriptome changes | Identifying pathways in valve development |
| In situ hybridization | Spatial gene expression | Localizing Notch1, Shox2 in embryos [1,8] |
| Optical coherence tomography | 3D valve morphology | Studying dogfish SA valve |
| Lineage tracing | Cell fate mapping | Endocardial contribution to valves |
| Pharmacological inhibition | Pathway activity | Hedgehog inhibitor treatment |
| Translational profiling (Ribo-seq) | mRNA translation efficiency | Furina RNA regulon |
Genetic lineage tracing and conditional knockout
Conditional knockout models, such as endothelial-specific Notch1 deletion, have been instrumental in defining the role of NOTCH1 in sinoatrial valve development. Lineage tracing using Cre-lox systems allows visualization of endocardial contributions to the valve.
Imaging and morphological analysis
High-resolution imaging techniques, including confocal microscopy and optical coherence tomography, enable detailed analysis of valve morphology in embryonic hearts. These methods have been used to study sinoatrial valve anatomy in dogfish.
Transcriptomics and bioinformatics
RNA sequencing and single-cell transcriptomics can identify gene expression programs during sinoatrial valve development. Bioinformatics analyses of public datasets can reveal co-regulated modules and candidate regulators.
Functional assays in animal models
Zebrafish and mouse models allow functional testing of candidate genes through CRISPR/Cas9 mutagenesis or morpholino knockdown. For example, Hedgehog pathway mutants display defects in sinoatrial node and cushion formation.
How CRISPR Can Be Used to Study GO:0003172 sinoatrial valve development
Knockout
CRISPR/Cas9-mediated knockout of genes such as Notch1 or Shox2 in animal models recapitulates developmental defects in sinoatrial valve formation, enabling causal inference [1,8]. These models are essential for validating gene function in vivo.
Point Mutation
Introducing precise point mutations (e.g., in Shox2 or Notch1) can model human variants associated with congenital heart defects and arrhythmias, allowing study of specific amino acid changes on valve development.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci facilitates live imaging and biochemical analysis of proteins involved in sinoatrial valve development.
Overexpression
Overexpression of candidate genes (e.g., constitutively active Notch1) using CRISPR knock-in of strong promoters can test sufficiency in driving valve formation or malformation.
How EDITGENE Supports sinoatrial valve development Research
Researchers studying sinoatrial valve development-related genes often need to determine whether a candidate gene is causally involved in valve morphogenesis or merely correlated with the process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for sinoatrial valve development research.
Frequently Asked Questions About sinoatrial valve development
What is GO:0003172 sinoatrial valve development?
GO:0003172 is a Gene Ontology biological process term defined as the progression of the sinoatrial valve over time, from its formation to the mature structure.
What genes are involved in sinoatrial valve development?
Key genes include NOTCH1, Shox2, and Hedgehog signaling components, as shown by experimental studies [1,3,8].
Why is sinoatrial valve development important?
It is essential for proper heart function and its disruption can lead to congenital heart defects and arrhythmias [1,8].
How is sinoatrial valve development studied?
Researchers use animal models, conditional knockouts, imaging, and transcriptomics to study this process [1,5,6].
What signaling pathways regulate sinoatrial valve development?
NOTCH1 and Hedgehog signaling are critical regulators, along with transcription factors like Shox2 [1,3,8].
What diseases are associated with defective sinoatrial valve development?
Congenital heart defects, sinus node dysfunction, and arrhythmias have been linked to defects in this process [1,8].
What is the role of NOTCH1 in sinoatrial valve development?
Endocardial NOTCH1 signaling is required for sinus venosus valve and sinoatrial node development.
How does Shox2 affect sinoatrial valve development?
Shox2 mutation disrupts sinoatrial and pacemaking development, including SA valve formation.
Can CRISPR be used to study sinoatrial valve development?
Yes, CRISPR/Cas9 enables knockout, point mutation, knock-in, and overexpression models to study gene function in this process [1,8].
What model organisms are used for sinoatrial valve research?
Mouse, zebrafish, and dogfish are commonly used to study sinoatrial valve development [1,3,5].
Conclusion
Sinoatrial valve development (GO:0003172) is a critical biological process that integrates signaling pathways and transcription factors to form a functional valve in the embryonic heart. Research has elucidated key roles for NOTCH1, Hedgehog signaling, and Shox2, linking valve development to pacemaker formation and disease [1,3,8]. Understanding these mechanisms offers insights into congenital heart defects and potential therapeutic targets. EDITGENE provides advanced CRISPR services to support functional studies of genes involved in sinoatrial valve development, empowering researchers to uncover new regulatory mechanisms and disease models.
References
- 1. Wang Y et al.. 2020. Control of sinus venous valve and sinoatrial node development by endocardial NOTCH1.. Cardiovasc Res 116(8):1473-1486 PMID: 31591643
- 3. Zhang C et al.. 2021. Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation.. Open Biol 11(6):210020 PMID: 34062094
- 5. Gallego A et al.. 1997. Anatomy and development of the sinoatrial valves in the dogfish (Scyliorhinus canicula).. Anat Rec 248(2):224-32 PMID: 9185988
- 6. Faber JW et al.. 2019. Sinus venosus incorporation: contentious issues and operational criteria for developmental and evolutionary studies.. J Anat 234(5):583-591 PMID: 30861129
- 7. Nagorska A et al.. 2023. Translational control of furina by an RNA regulon is important for left-right patterning, heart morphogenesis and cardiac valve function.. Development 150(23) PMID: 38032088
- 8. Blaschke RJ et al.. 2007. Targeted mutation reveals essential functions of the homeodomain transcription factor Shox2 in sinoatrial and pacemaking development.. Circulation 115(14):1830-8 PMID: 17372176
